Citation:Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, et al 2013

Citation

Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic S, Giaccone G, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. J Thorac Oncol 2013 Jul;8(7):823-59 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23552377.

Critical appraisals

• Assign a critical appraisal

Cited by

1. What specimen types are suitable for mutation testing in NSCLC patients?
2. Which histological subtype should undergo mutation testing?